Rohto Pharmaceutical

Rohto Pharmaceutical Co., Ltd.
Native name
ロート製薬株式会社
Rōto Seiyaku kabushiki gaisha
Company typePublic KK
TYO: 4527
Industry
FoundedHigashinari-ku, Osaka, Japan (September 15, 1949 (1949-09-15), to reorganize "Shintendo, Yasutami Yamada pharmaceutical Company")
FounderYasutami Yamada
HeadquartersIkuno-ku, Osaka, Japan
Key people
  • Kunio Yamada (chair and CEO, great-grandson of the founder)
  • Toshiaki Yoshino (president and COO)
Revenue
  • Increase¥120,292 million (FY 2011)[* 1]
  • ¥115,472 million (FY 2010)
  • Increase¥13,624 million (FY 2011)[* 1]
  • ¥13,105 million (FY 2010)
  • Increase¥8,184 million (FY 2011)[* 1]
  • ¥7,966 million (FY 2010)
Total assets
  • Increase¥136,008 million (FY 2011)[* 1]
  • ¥126,472 million (FY 2010)
Total equity
  • Increase¥83,627 million (FY 2011)[* 1]
  • ¥77,911 million (FY 2010)
Number of employees
5,518 (March 31, 2013)
SubsidiariesMentholatum
Rohto Advanced Research Hong Kong Ltd
Websitewww.rohto.co.jp/global/
Footnotes / references
  1. ^ a b c d e "Financial Results for the Fiscal Year Ended March 31, 2012" (PDF). Rohto Pharmaceutical Co., Ltd. May 11, 2012. Retrieved November 12, 2012.

Rohto Pharmaceutical Co., Ltd. (ロート製薬株式会社, Rōto Seiyaku Kabushiki-gaisha) is a multinational corporation in fast-moving consumer goods and pharmaceutical corporation headquartered in Ikuno-ku, Osaka, Japan. with revenues steadily increasing from ¥95,619 million in 2006 to ¥120,292 million in 2011. Skin care contributes to 61.3% of the revenues, while Eye Care contributes to 21% of their sales.